Retatrutide is being studied in that same general category of peptide weight loss therapy , but with an important twist: it is designed as a triple-agonist. What that means is that retatrutide targets three receptors involved in weight regulation and metabolism: GLP-1 , which supports satiety and improves glucose control GIP , another incretin hormone involved in metabolic signaling Glucagon receptors , which are linked to energy balance and how the body uses fuel This three-pronged approach is a big reason its creating buzz
Cholesterol: 83mg
Certificado de anlisis por lote Lotes de Retatrutida con certificado de anlisis publicado en el catlogo de COA: Lote EXO010626027A 30 mg, emitido 2026-05-21 Lote EXO010626027B 15 mg, emitido 2026-05-22 Lote EXO010626027C 5 mg, emitido 2026-05-25 Lote EXO010626027D 10 mg, emitido 2026-05-22 Lote EXO010626027E 40 mg, emitido 2026-05-21 Lote EXO010626027F 50 mg, emitido 2026-05-23 Lote EXO010626027G 60 mg, emitido 2026-05-19 Lote EXO010626027H 20 mg, emitido 2026-05-27 Lote EXO010626027J 100 mg, emitido 2026-05-22 Ficha cientfica completa: Retatrutide en el compendio mecanismo de accin, estudios y ficha tcnica.
This makes it one of the cheapest cash-pay options for GLP-1s, especially for those comfortable with compounded semaglutide
